Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.

Publication Type:

Journal Article

Authors:

Schadendorf, Dirk; Hodi, F Stephen; Robert, Caroline; Weber, Jeffrey S; Margolin, Kim; Hamid, Omid; Patt, Debra; Chen, Tai-Tsang; Berman, David M; Wolchok, Jedd D

Source:

Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2015)

Abstract:

To provide a more precise estimate of long-term survival observed for ipilimumab-treated patients with advanced melanoma, we performed a pooled analysis of overall survival (OS) data from multiple studies.